Cambridge Investment Research Advisors, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$276
+6.2%
7,234
+0.2%
0.00%0.0%
Q2 2023$260
-16.1%
7,218
-11.1%
0.00%
-50.0%
Q1 2023$310
-35.7%
8,119
-4.2%
0.00%
-33.3%
Q4 2022$482
-99.9%
8,475
-5.6%
0.00%
+50.0%
Q3 2022$355,000
+3.8%
8,980
+15.7%
0.00%0.0%
Q2 2022$342,000
+13.2%
7,762
+2.6%
0.00%
+100.0%
Q1 2022$302,000
-5.3%
7,562
-4.7%
0.00%0.0%
Q4 2021$319,000
+15.2%
7,934
+16.6%
0.00%0.0%
Q3 2021$277,000
+16.9%
6,806
+30.4%
0.00%0.0%
Q2 2021$237,000
-7.8%
5,218
-15.3%
0.00%0.0%
Q1 2021$257,000
-1.9%
6,157
+0.4%
0.00%
-50.0%
Q4 2020$262,000
+3.6%
6,134
-35.0%
0.00%0.0%
Q2 2020$253,000
+36.0%
9,435
-10.0%
0.00%
+100.0%
Q4 2019$186,000
+13.4%
10,483
-0.9%
0.00%0.0%
Q3 2019$164,000
-14.6%
10,582
-5.4%
0.00%
-50.0%
Q2 2019$192,000
+2.1%
11,182
-4.3%
0.00%0.0%
Q1 2019$188,000
+13.9%
11,682
+3.4%
0.00%0.0%
Q4 2018$165,000
-19.5%
11,3000.0%0.00%0.0%
Q3 2018$205,00011,3000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders